CFM
CRMD icon

Cornerstone Financial Management’s CorMedix CRMD Stock Holding History

Cornerstone Financial Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23K Hold
157
– – ﹤0.01% 1012
2026
Q1 		$1.07K Hold
157
– – ﹤0.01% 943
2025
Q4 		$1.83K Buy
+157
New +$1.74K ﹤0.01% 717

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $4.84B AUM 160.95% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Cornerstone Financial Management's CRMD Position: Q2 2026 in Review

Cornerstone Financial Management held its CorMedix (CRMD) position steady in Q2 2026 at 157 shares worth $1.23K. The position accounts for ﹤0.01% of the portfolio, ranked #1012.

Cornerstone Financial Management first reported a position in CRMD in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.83K in Q4 2025. 194 funds tracked by Wall St. Rank hold CRMD as of Q2 2026.

  • Cornerstone Financial Management held 157 shares of CorMedix worth $1.23K as of Q2 2026.
  • Cornerstone Financial Management left its CorMedix share count unchanged in Q2 2026.
  • CorMedix made up ﹤0.01% of Cornerstone Financial Management's portfolio in Q2 2026, its #1012 holding.
  • Cornerstone Financial Management first reported a position in CorMedix in Q4 2025 and has held it in 3 quarters since.
  • Cornerstone Financial Management's CorMedix position peaked at $1.83K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held CorMedix as of Q2 2026.

Based on Cornerstone Financial Management's 13F filing for Q2 2026, filed 12 Aug 2026.